Connect your AI

Apimeds Pharmaceuticals US, Inc. APUS Q3 2024 earnings

Reported September 30, 2024

Diluted EPS-$0.03

Next report

Date not yet announced

Versus estimates

Diluted EPS

Q1 2026-$2.26 Q3 2025-$0.14 Q2 2025-$0.26 Q1 2025-$0.05 Q4 2024-$0.02

Q3 2024-$0.03

Ask the moment Apimeds Pharmaceuticals US, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk

Questions, answered.

When did Apimeds Pharmaceuticals US, Inc. report Q3 2024 earnings?: Apimeds Pharmaceuticals US, Inc. (APUS) reported Q3 2024 earnings on September 30, 2024.
What were Apimeds Pharmaceuticals US, Inc.'s Q3 2024 revenue and EPS?: Apimeds Pharmaceuticals US, Inc. reported diluted EPS of $-0.03 for Q3 2024.